Substrate stiffness regulates alveolar epithelial cell behavior
基质硬度调节肺泡上皮细胞行为
基本信息
- 批准号:7777884
- 负责人:
- 金额:$ 38.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-01 至 2014-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Lung InjuryAdenovirusesAdhesionsAdult Respiratory Distress SyndromeAlveolarAnimal ModelAnimalsBasal laminaBehaviorBiological AssayBleomycinCell Differentiation processCell Surface ReceptorsCell physiologyCessation of lifeCollagenConnective TissueDataDepositionDevelopmentDiseaseDisease ProgressionDystroglycanEnvironmentEpithelialEpithelial CellsExhibitsExtracellular MatrixFibrosisFutureGrowth FactorHamman-Rich syndromeIn SituIn VitroKnock-outKnockout MiceLamininLungLung diseasesMediatingMesenchymalMortality DeterminantsMusMyofibroblastOutcomePatientsPhenotypeProteinsPublishingPulmonary FibrosisResolutionRespiratory physiologyRoleScaffolding ProteinSeriesSignal PathwaySignal TransductionStructure of parenchyma of lungTestingTissuesalveolar epitheliumbasecell behaviorcell motilitycell typein vivoinjuredinsightlung injurymigrationmouse modelnovelplectinpublic health relevancereceptorrepaired
项目摘要
DESCRIPTION (provided by applicant): In patients with acute lung injury (ALI) or the adult respiratory distress syndrome (ARDS), disordered repair of the injured alveolar epithelium can result in lung fibrosis. Fibrosis is associated with aberrant accumulation of a collagen-rich extracellular matrix in the lung parenchyma that results in tissue stiffness and a progressive decline in lung function. We will test the hypothesis that the tissue in fibrosis induces alveolar epithelial cells (AEC) to deposit matrix enriched in the (3 laminin subunit which functions, via the cell surface receptor dystroglycan and the signaling scaffold protein plectin, to protect AEC from the harmful impact of the fibrotic milieu. To test this hypothesis, in Aim 1, we will assay (3 laminin matrix deposition in situ in normal and fibrotic lungs and in AEC maintained in vitro on substrates of varying stiffness. In Aim 2, we will evaluate the role of ?3 laminin, dystroglycan and plectin in mediating the survival, adhesion, migration, proliferation and differentiation of AEC maintained on substrate of varying stiffness. In Aim 3, we will assess whether the absence of the (3 laminin enhances fibrosis and inhibits disease resolution in two different mouse models of lung disease. In this aim, we propose to use an inducible lung specific (3 laminin subunit knockout mouse line. Lung fibrosis in our knockout and control mice will be initiated by treatment of animals with bleomycin or by the intratracheal instillation of an adenovirus encoding active TGF-(1. Our aims will provide new insights into the mechanisms that underlie the variable development of fibrosis after acute lung injury, a major determinant of outcome in patients with ALI/ARDS. PUBLIC HEALTH RELEVANCE: In certain pulmonary diseases, lung tissue becomes fibrotic and stiffens. We propose to assay how the stiffness of the lung regulates the function of its cellular components. Our results will provide novel insight into the mechanisms of disease progression and has implications for future therapies.
描述(由申请人提供):在急性肺损伤(ALI)或成人呼吸窘迫综合征(ARDS)患者中,受损肺泡上皮的修复障碍可导致肺纤维化。纤维化与富含胶原的细胞外基质在肺实质中的异常积累相关,其导致组织僵硬和肺功能的进行性下降。我们将检验纤维化组织诱导肺泡上皮细胞(AEC)存款富含β层粘连蛋白亚基的基质的假设,所述β层粘连蛋白亚基通过细胞表面受体肌营养不良蛋白聚糖和信号传导支架蛋白质网蛋白发挥功能,以保护AEC免受纤维化环境的有害影响。为了验证这一假设,在目标1中,我们将在正常和纤维化肺中以及在不同硬度的基质上体外维持的AEC中原位测定β层粘连蛋白基质沉积。在目标2中,我们将评估的作用?3层粘连蛋白、肌营养不良蛋白聚糖和类凝集素介导AEC在不同硬度基质上的存活、粘附、迁移、增殖和分化。在目标3中,我们将评估β层粘连蛋白的缺乏是否在两种不同的肺部疾病小鼠模型中增强纤维化并抑制疾病消退。在这个目标中,我们建议使用诱导型肺特异性β层粘连蛋白亚基敲除小鼠系。在我们的基因敲除小鼠和对照小鼠中,肺纤维化将通过用博来霉素治疗动物或通过肺内滴注编码活性TGF-β 1的腺病毒来启动。我们的目的是提供新的见解,在急性肺损伤后纤维化的变化发展的基础上的机制,在ALI/ARDS患者的结果的主要决定因素。公共卫生相关性:在某些肺部疾病中,肺组织变得纤维化和僵硬。我们建议分析肺的硬度如何调节其细胞成分的功能。我们的研究结果将为疾病进展的机制提供新的见解,并对未来的治疗方法产生影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GR Scott Budinger其他文献
GR Scott Budinger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GR Scott Budinger', 18)}}的其他基金
Targeting abnormal alveolar immune activation and failed epithelial repair in COVID-19
针对 COVID-19 中异常的肺泡免疫激活和失败的上皮修复
- 批准号:
10596990 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Microglia mediate cognitive dysfunction in elderly survivors of pneumonia
小胶质细胞介导老年肺炎幸存者的认知功能障碍
- 批准号:
10354214 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Targeting abnormal alveolar immune activation and failed epithelial repair in COVID-19
针对 COVID-19 中异常的肺泡免疫激活和失败的上皮修复
- 批准号:
10391970 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Project 3: Targeting linear ubiquitination to attenuate inflammation and promote repair after viral pneumonia
项目3:靶向线性泛素化以减轻病毒性肺炎后的炎症并促进修复
- 批准号:
10696965 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
Project 3: Targeting linear ubiquitination to attenuate inflammation and promote repair after viral pneumonia
项目3:靶向线性泛素化以减轻病毒性肺炎后的炎症并促进修复
- 批准号:
10269676 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
Disordered Proteostasis as a Driver of Disease in the Aging Lung
蛋白质稳态紊乱是衰老肺疾病的驱动因素
- 批准号:
10208506 - 财政年份:2015
- 资助金额:
$ 38.13万 - 项目类别:
Disordered Proteostasis as a Driver of Disease in the Aging Lung
蛋白质稳态紊乱是衰老肺疾病的驱动因素
- 批准号:
10197736 - 财政年份:2015
- 资助金额:
$ 38.13万 - 项目类别:
Alveolar Macrophages as Age-Related Drivers of Disordered Tissue Repair
肺泡巨噬细胞作为紊乱组织修复的年龄相关驱动因素
- 批准号:
10197742 - 财政年份:2015
- 资助金额:
$ 38.13万 - 项目类别:
Alveolar Macrophages as Age-Related Drivers of Disordered Tissue Repair
肺泡巨噬细胞作为紊乱组织修复的年龄相关驱动因素
- 批准号:
10417059 - 财政年份:2015
- 资助金额:
$ 38.13万 - 项目类别:
Disordered Proteostasis as a Driver of Disease in the Aging Lung
蛋白质稳态紊乱是衰老肺疾病的驱动因素
- 批准号:
9751135 - 财政年份:2015
- 资助金额:
$ 38.13万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Roles of N-glycans on neutrophil beta2 integrins in progression of acute lung injury
N-聚糖对中性粒细胞β2整合素在急性肺损伤进展中的作用
- 批准号:
10837431 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:














{{item.name}}会员




